165 related articles for article (PubMed ID: 2552180)
21. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
[TBL] [Abstract][Full Text] [Related]
22. Molecular and biological characterization of a type 1 herpes simplex virus (HSV-1) specifically deleted for expression of the latency-associated transcript (LAT).
Izumi KM; McKelvey AM; Devi-Rao G; Wagner EK; Stevens JG
Microb Pathog; 1989 Aug; 7(2):121-34. PubMed ID: 2556619
[TBL] [Abstract][Full Text] [Related]
23. The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice.
Hay KA; Gaydos A; Tenser RB
J Neuroimmunol; 1995 Aug; 61(1):41-52. PubMed ID: 7560011
[TBL] [Abstract][Full Text] [Related]
24. Use of [125I]deoxycytidine to detect herpes simplex virus-specific thymidine kinase in tissues of latently infected guinea pigs.
Fong BS; Scriba M
J Virol; 1980 Jun; 34(3):644-9. PubMed ID: 6247502
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.
Sawtell NM; Thompson RL
J Virol; 1992 Apr; 66(4):2157-69. PubMed ID: 1312626
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.
Sears AE; Halliburton IW; Meignier B; Silver S; Roizman B
J Virol; 1985 Aug; 55(2):338-46. PubMed ID: 2991560
[TBL] [Abstract][Full Text] [Related]
27. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.
Field HJ; Wildy P
J Hyg (Lond); 1978 Oct; 81(2):267-77. PubMed ID: 212476
[TBL] [Abstract][Full Text] [Related]
28. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
[TBL] [Abstract][Full Text] [Related]
29. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
30. Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.
Stanberry LR; Kit S; Myers MG
J Virol; 1985 Aug; 55(2):322-8. PubMed ID: 2991558
[TBL] [Abstract][Full Text] [Related]
31. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
32. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.
Tenser RB; Edris WA
J Virol; 1987 Jul; 61(7):2171-4. PubMed ID: 3035217
[TBL] [Abstract][Full Text] [Related]
33. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
MacLean A; Robertson L; McKay E; Brown SM
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2305-10. PubMed ID: 1654382
[TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia.
Jacobson JG; Ruffner KL; Kosz-Vnenchak M; Hwang CB; Wobbe KK; Knipe DM; Coen DM
J Virol; 1993 Nov; 67(11):6903-8. PubMed ID: 8411396
[TBL] [Abstract][Full Text] [Related]
35. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.
Whitley RJ; Kern ER; Chatterjee S; Chou J; Roizman B
J Clin Invest; 1993 Jun; 91(6):2837-43. PubMed ID: 8390490
[TBL] [Abstract][Full Text] [Related]
36. Does restriction enzyme analysis reveal changes in herpes simplex virus DNA after latency in mouse ganglia?
Wolff MH; Krämer S; Schneweis KE
Microbiologica; 1986 Apr; 9(2):139-45. PubMed ID: 3012286
[TBL] [Abstract][Full Text] [Related]
37. Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: infection of the PC 12 cell.
Rubenstein R; Price RW
Arch Virol; 1983; 78(1-2):49-64. PubMed ID: 6316875
[TBL] [Abstract][Full Text] [Related]
38. Competition and complementation between thymidine kinase-negative and wild-type herpes simplex virus during co-infection of mouse trigeminal ganglia.
Chen SH; Lin YW; Griffiths A; Huang WY; Chen SH
J Gen Virol; 2006 Dec; 87(Pt 12):3495-3502. PubMed ID: 17098963
[TBL] [Abstract][Full Text] [Related]
39. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.
Griffiths A; Link MA; Furness CL; Coen DM
J Virol; 2006 Jul; 80(13):6568-74. PubMed ID: 16775343
[TBL] [Abstract][Full Text] [Related]
40. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
Besecker MI; Furness CL; Coen DM; Griffiths A
J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
